|Ways forward to identify new ACPA targets in RA.|
|Jump to Full Text|
|PMID: 23025589 Owner: NLM Status: Publisher|
|ABSTRACT: Anti-citrullinated protein antibodies (ACPAs) of the IgG subtype have become a critical hallmark of HLA-associated rheumatoid arthritis (RA) and point to important contributions from the adaptive immune system. To dissect the contributing autoimmune reactions, investigators must not only identify the protein targets of ACPA but also define the precise peptides recognized by the immune system. Several possible approaches could be used to achieve this goal, and sensitive mass spectrometry of relevant tissue is a promising way forward in advancing our detailed understanding of autoimmune immune reactions involved in RA pathogenesis.|
|A Jimmy Ytterberg; Vivianne Malmström|
Related Documents :
|23569139 - Expression of dendritic cell lysosome-associated membrane protein and dendritic cell-sp...
21267569 - Polyethylene and metal wear particles: characteristics and biological effects.
23405029 - Expression of innate immune genes, proteins and micrornas in lung tissue of pigs infect...
17203169 - Immortalized ovarian surface epithelial cells acquire tumorigenicity by acrogranin gene...
9396739 - Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor an...
21518319 - Chondrocyte death by apoptosis is associated with the initiation and severity of articu...
21160069 - Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.
3304809 - Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer ...
25394289 - Pound the alarm: danger signals in rheumatic diseases.
|Type: JOURNAL ARTICLE Date: 2012-9-24|
|Title: Arthritis research & therapy Volume: 14 ISSN: 1478-6362 ISO Abbreviation: Arthritis Res. Ther. Publication Date: 2012 Sep|
|Created Date: 2012-10-2 Completed Date: - Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 101154438 Medline TA: Arthritis Res Ther Country: -|
|Languages: ENG Pagination: 124 Citation Subset: -|
|Rheumatology Unit, Dept Of Medicine, CMM L8:04, Karolinska University Hospital Solna, Karolinska Institutet, SE-171 76 Stockholm, Sweden. Vivianne.Malmstrom@ki.se.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Arthritis Res Ther
Journal ID (iso-abbrev): Arthritis Res. Ther
Publisher: BioMed Central
Copyright ©2012 BioMed Central Ltd
Print publication date: Year: 2012
Electronic publication date: Day: 24 Month: 9 Year: 2012
pmc-release publication date: Day: 24 Month: 3 Year: 2013
Volume: 14 Issue: 5
First Page: 124 Last Page: 124
PubMed Id: 23025589
Publisher Id: ar4031
|Ways forward to identify new ACPA targets in RA|
|A Jimmy Ytterberg1||Email: Vivianne.Malmstrom@ki.se|
|Vivianne Malmström1||Email: Vivianne.Malmstrom@ki.se|
1Rheumatology Unit, Dept Of Medicine, CMM L8:04, Karolinska University Hospital Solna, Karolinska Institutet, SE-171 76 Stockholm, Sweden
In a recent issue of Arthritis Research & Therapy, Raijmakers and colleagues  use an unbiased approach via mass spectrometry to identify candidate citrullinated peptides that have the potential to be involved in rheumatoid arthritis (RA). By sampling synovial fluid from a number of patients with RA as well as from non- RA disease control subjects, the authors demonstrate that it is possible to broaden the arsenal of potential autoantigenic peptides that deserve further investigation as candidate B- or T-cell epitopes in the setting of anticitrullinated protein antibody (ACPA)-positive RA disease.
Why citrullination, a common physiological protein modification, is regarded as such a threat to the immune system in patients with RA and causes more than 60% of patients to mount autoantibody titers (ACPA) remains an enigma. One underlying reason is the strong bias toward a certain set of HLA class II alleles that are very capable of presenting this altered amino acid [2,3], but that is not enough. In fact, most individuals carrying the HLA shared epitope alleles do not develop RA. Clearly, these autoimmune reactions must be triggered, and here environmental provocations (smoking, bacterial infection in the gum, and so on) have become an intriguing hypothesis (reviewed in ).
A central function of citrullination is to contribute to structure (for example, in the skin, hair follicles, central nervous system, and histones). Another, partly related, function is to destabilize proteins and mark them for degradation. In most cases, the regulated step in degradation of proteins is initial cleavage followed by rapid removal of the degradation products. The commonality of ACPAs in patients with RA suggests that citrullinated proteins are readily exposed to the immune system. Indeed, citrullinated proteins are found and even abundant at many sites of inflammation . ACPA targets are probably a mix of degradation products and secreted or cell-bound proteins [6,7]. In their study, Raijmakers and colleagues demonstrate that synovial fluid of patients with RA and, to lesser degree, that of disease control subjects accumulate fibrinogen degradation products and that the peptides thereof are citrullinated (to a small but significant degree).
In the last few years, several studies that present either improved methods for the identification of citrullinated peptides or new citrullinated targets present in biological tissues have been published (reviewed in ). Citrullination of arginines can easily be confused with deamidation of asparagine or glutamine, and this potential confusion makes correct assignments of citrullinated peptides very important. The present study illustrates several characteristics that are diagnostic for citrulline species, such as a decrease in the precursor charge state, shifts in retention time when reverse-phase chromatography is used, and changes in the relative abundance of the ions in tandem mass spectrometry. With this approach, citrullinated peptides from a variety of sources [9,10] can be identified and validated.
The next step is to evaluate whether these 'suspects' are indeed involved in immune reactions and, if so, the nature of these responses. Understanding the chronic autoimmune reactions in affected joints may hold critical clues toward ways of reversing them and re-establishing a tolerogenic state.
An even broader vision of current RA research entails preventive measurements toward disease development. Dissecting disease-initiating events (since ACPAs appear before clinical onset) will require access to different material from subjects at risk of disease. Time will tell what technical platforms will help us dissect ACPA targets in this setting. Clearly, unbiased approaches such as the one described in the present study are very attractive.
ACPA: anti-citrullinated protein antibody; RA: rheumatoid arthritis.
The authors declare that they have no competing interests.
|Raijmakers R,van Beers JJ,El-Azzouny M,Visser NF,Bozic B,Pruijn GJ,Heck AJ,Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patientsArthritis Res TherYear: 201214R11410.1186/ar384022584083|
|Hill JA,Southwood S,Sette A,Jevnikar AM,Bell DA,Cairns E,Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II moleculeJ ImmunolYear: 200317153854112847215|
|Snir O,Rieck M,Gebe JA,Yue BB,Rawlings CA,Nepom G,Malmström V,Buckner JH,Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patientsArthritis RheumYear: 2011632873288310.1002/art.3044521567378|
|Klareskog L,Malmström V,Lundberg K,Padyukov L,Alfredsson L,Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritisSemin ImmunolYear: 201123929810.1016/j.smim.2011.01.01421376627|
|Makrygiannakis D,af Klint E,Lundberg IE,Lofberg R,Ulfgren AK,Klareskog L,Catrina AI,Citrullination is an inflammation-dependent processAnn Rheum DisYear: 2006651219122210.1136/ard.2005.04940316540548|
|Bae S,Kim H,Lee N,Won C,KIm HR,Hwang YI,Song YW,Kang JS,Lee WJ,alpha-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritisJ ImmunolYear: 201218936537210.4049/jimmunol.110207322623332|
|Harre U,Georgess D,Bang H,Bozec A,Axmann R,Ossipova E,Jakobsson PJ,Baum W,Nimmerjahn F,Szarka E,Sarmay G,Krumbholz G,Neumann E,Toes R,Scherer HU,Catrina AI,Klareskog L,Jurdic P,Schett G,Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentinJ Clin InvestYear: 20121221791180210.1172/JCI6097522505457|
|De Ceuleneer M,Van Steendam K,Dhaenens M,Deforce D,vivo relevance of citrullinated proteins and the challenges in their detectionProteomicsYear: 20121275276010.1002/pmic.20110047822318877|
|Hermansson M,Artemenko K,Ossipova E,Eriksson H,Lengqvist J,Makrygiannakis D,Catrina AI,Nicholas AP,Klareskog L,Savitski M,Zubarev RA,Jakobsson PJ,MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogenProteomics Clin ApplYear: 2010451151821137068|
|Ytterberg AJ,Reynisdottir G,Ossipova E,Rutishauser D,Hensvold A,Eklund A,Sköld M,Grunewald J,Lundberg K,Malmström V,Jakobsson PJ,Zubarev RA,Klareskog L,Catrina AI,Identification of shared immunological targets in the lungs and joints of patients with rheumatoid arthritisAnn Rheum DisYear: 201271A19|
Previous Document: Aluminum-doped ceria-zirconia solid solutions with enhanced thermal stability and high oxygen storag...
Next Document: Spatial and temporal variation of whirling disease risk in montana spring creeks and rivers.